e4shieldtm, the technology conceived, developed and patented by ELT Group that uses electromagnetic waves for the inactivation of airborne respiratory viruses, has been included and positively evaluated in the JRC – HERA technology prospective study.
The European Commission’s Joint Research Centre (JRC) provides scientific support to the European Union in establishing future guidelines/regulations with the aim of improving quality of life, such as by supporting the development and implementation of innovative technologies. Specifically, the report “Suppressing indoor pathogen transmission: A Technology Foresight study” includes e4shieldtm among the innovative technologies that need to be considered in the EU’s future to ensure increased indoor air quality.
In fact, even according to this study, the airborne route is considered one of the most common modes of transmission of respiratory viruses. This is particularly relevant in indoor environments, where most respiratory infections occur. Controlling the transmission of airborne pathogens has become a major public health challenge to prevent the spread of infectious diseases, ensuring the safety and health of individuals and communities. In order to meet this challenge, two groups of technologies have been identified, for airborne pathogen detection and for air and surface decontamination.
